-
Taxonomy & unit
-
us-gaap: CAD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Evome Medical Technologies Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q4 2023.
- Evome Medical Technologies Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -CA$1.32M, a 144% decline year-over-year.
- Evome Medical Technologies Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -CA$5.52M, a 339% decline year-over-year.
- Evome Medical Technologies Inc. annual Operating Income (Loss) for 2023 was -CA$5.52M.
- Evome Medical Technologies Inc. annual Operating Income (Loss) for 2021 was -CA$608K, a 40.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (CAD)
Operating Income (Loss), Quarterly (CAD)
Operating Income (Loss), YoY Quarterly Growth (%)